-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ta8IWiF6xac8DvvFLW6VVM+jYT9SAq1SJuK1DwGjXlHsbQ/mh0Igm6aQ41M2daXW sO14gHl6t29aiKVKWeeWpA== 0000897204-00-000107.txt : 20001218 0000897204-00-000107.hdr.sgml : 20001218 ACCESSION NUMBER: 0000897204-00-000107 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20001215 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0000095676 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 520898764 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-35771 FILM NUMBER: 790597 BUSINESS ADDRESS: STREET 1: 10240 OLD COLUMBIA RD STREET 2: STE 100 CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 4103096830 MAIL ADDRESS: STREET 1: 10240 OLD COLUMBIA ROAD CITY: COLUMBIA STATE: DE ZIP: 21046- FORMER COMPANY: FORMER CONFORMED NAME: SURVIVAL TECHNOLOGY INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EM INDUSTRIES INC CENTRAL INDEX KEY: 0001027682 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 132666399 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 7 SKYLINE DRIVE CITY: HAWTHORNE STATE: NY ZIP: 10532 BUSINESS PHONE: 9145924660 SC 13D 1 0001.txt MERIDIAN MEDICAL TECHNOLOGIES SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 2) Meridian Medical Technologies, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.10 per share --------------------------------------------------------- (Title of Class of Securities) 589658 10 3 - -------------------------------------------------------------------------------- (Cusip Number) Stephen J. Kunst, Esq. EM Industries, Incorporated 7 Skyline Drive Hawthorne, NY 10532 (914) 592-4660 and Klaus H. Jander, Esq. Clifford Chance Rogers & Wells LLP 200 Park Avenue New York, NY 10166 (212) 878-8000 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 30, 2000 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box |_| Note. Schedules filed in paper format should include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for the other parties to whom copies are to be sent. (Continued on following pages) (Page 1 of 5 Pages) NYA 323074.1 - --------------------------------- ------------------------------- CUSIP No. 589658 10 3 13D Page 2 of 5 Pages - --------------------------------- ------------------------------- ============ =================================================================== 1. NAMES OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) EM. Industries, Incorporated - ------------ ------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)|_| (b)|_| - ------------ ------------------------------------------------------------------- 3. SEC USE ONLY - ------------ ------------------------------------------------------------------- 4. SOURCES OF FUNDS OO - ------------ ------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) |_| - ------------ ------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION New York - ------------------------- ------- ---------------------------------------------- 7. SOLE VOTING POWER NUMBER OF UNITS 230,276(1) BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ------- ---------------------------------------------- 8. SHARED VOTING POWER 0 ------- ---------------------------------------------- 9. SOLE DISPOSITIVE POWER 230,276(1) ------- ---------------------------------------------- 10. SHARED DISPOSITIVE POWER 0 - ------------ ------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 230,276(1) - ------------ ------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES |-| - ------------ ------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 7.6% - ------------ ------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON CO ============ =================================================================== (1) Includes 29,038 shares of Common Stock of the issuer subject to presently exercisable warrants. SCHEDULE 13D FILED PURSUANT TO RULE 13d-1 OF THE GENERAL RULES AND REGULATIONS UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED This Amendment No. 2, which relates to shares of the common stock, par value $0.10 per share (the "Common Stock") of Meridian Medical Technologies, Inc. (the "Issuer") and is being filed by EM Industries, Incorporated, supplements and amends the statement on Schedule 13D, dated November 20, 1996, and originally filed with the Commission on December 2, 1996, and Amendment No. 1 thereto, dated October 24, 2000, and filed with the Commission on October 26, 2000. Item 4. Purpose of the Transaction. Item 4 of Schedule 13D is amended by the addition of the following: As described in Amendment No. 1 to the Schedule 13D, EM intends to dispose of the Common Stock and Warrants that it holds. Since the filing of Amendment No. 1, EM has sold, as of the date of this Amendment No. 2 to the Schedule 13D, a total of 13,200 shares of Common Stock in market transactions at then prevailing market prices, as set forth below in part (c) of Item 5. EM intends to continue to dispose of its Common Stock and Warrants in an orderly fashion, as market conditions permit and at prices acceptable to it. It will continue to hold its Common Stock and Warrants to the extent that these objectives cannot be achieved. EM's decision to dispose of its interest in the Issuer was based on the fact that its commercial relationship with the Issuer has been assigned to an affiliate of EM, that EM's investment in the Issuer was unrelated to its current strategic plans, and that its investment in the Issuer had appreciated in value, and was not based on an evaluation of the Issuer's future prospects. Item 5. Interest in Securities of the Issuer. Part (a) of Item 5 of Schedule 13D is deleted and amended to read in its entirety as follows: (a) EM directly owns 201,238 shares of Common Stock and Warrants to purchase 29,038 shares of Common Stock (together, the "EM Common Shares"), which amounts include the shares of Common Stock and Warrants acquired in the Merger plus 61,989 shares of Common Stock previously acquired by EM from STI in November 1992 in a privately negotiated transaction. Based in part upon information provided by the Issuer and calculated in accordance with Rule 13d-3(d)(1) under the Exchange Act, the EM Common Shares represent 7.6% of (i) the 2,994,930 shares of Common Stock outstanding on the date hereof plus (ii) the 29,038 shares of Common Stock issuable upon exercise of the Warrants. (c) Paragraph (c) of Item 5 of the Schedule 13D is amended by the addition of the following: During the last sixty days, EM has sold a portion of its shares of Common Stock in open market transactions as follows: -------------------- -------------- ----------------- Date Sold No. of Price per Share Shares Sold -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 7, 2000 500 $13.75 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 7, 2000 500 $13.50 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 7, 2000 300 $13.625 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 7, 2000 200 $13.50 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 8, 2000 5,000 $13.88 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 8, 2000 5,000 $14.00 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 10, 2000 100 $14.00 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 13, 2000 100 $14.00 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 14, 2000 1,000 $14.00 -------------------- -------------- ----------------- -------------------- -------------- ----------------- Nov. 14, 2000 500 $14,00 -------------------- -------------- ----------------- SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: December 15, 2000 EM INDUSTRIES, INCORPORATED By: /s/ Stephen J. Kunst Name: Stephen J. Kunst Title: Secretary and General Counsel -----END PRIVACY-ENHANCED MESSAGE-----